News

CHMP has issued a positive opinion supporting Laboratoires Pierre’ approval for Javlor. Also, it is recommending to grant marketing authorisation as monotherapy in metastatic treatment of bladder cancer.

Radiant Research is enrolling subjects and establishing operational plans for upcoming H1N1 vaccine trials. Michael Kritschgau, Vice President of Radiant, said: “We have over a million subjects in

Miraculins has finalized a research collaboration agreement with Diagnostic Technologies. The company has also announced the execution of a cooperation and project funding agreement with DTL and CIIRDF

CHMP of the European Medicines Agency (EMEA) has issued a positive opinion about Boehringer Ingelheim’s Mirapexin/Sifrol (pramipexole). It has recommended the approval of once daily formulation for Mirapexin/Sifrol

The Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion on Gilead’s Marketing Authorisation Application for aztreonam lysine 75mg powder and solvent for nebuliser

Antigenics has announced that Brain Tumor Research Center at the University of California (UCSF), has expanded phase-II clinical trial of Oncophage (vitespen) for glioma. The trial will now

Sandoz has received marketing authorization for the Japanese biosimilar, recombinant human growth hormone somatropin. The Ministry of Health, Labor and Wealth announced the approval on June 22, based

Teva and Active Biotech have announced the completion of patient enrollment for the second pivotal phase-III clinical trial, BRAVO. It is intended to evaluate oral once-daily immunomodulating compound,

Pfizer has announced the results from randomized phase-III trial of Sutent (sunitinib malate), in patients with advanced pancreatic islet cell tumors. Study demonstrated that median progression-free survival was